These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 15908974

  • 1. Donor CD31 genotype and its association with acute graft-versus-host disease in HLA identical sibling stem cell transplantation.
    Goodman RS, Ewing J, Evans PC, Craig J, Poulton K, Dyer PA, Marcus RE, Taylor CJ.
    Bone Marrow Transplant; 2005 Jul; 36(2):151-6. PubMed ID: 15908974
    [Abstract] [Full Text] [Related]

  • 2. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
    Elmaagacli AH, Koldehoff M, Landt O, Beelen DW.
    Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723
    [Abstract] [Full Text] [Related]

  • 3. Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation.
    Mlynarczewska A, Wysoczanska B, Karabon L, Bogunia-Kubik K, Lange A.
    Bone Marrow Transplant; 2004 Aug; 34(4):339-44. PubMed ID: 15235581
    [Abstract] [Full Text] [Related]

  • 4. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA, Visentainer JE.
    Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367
    [Abstract] [Full Text] [Related]

  • 5. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
    Sellami MH, Bani M, Torjemane L, Kaabi H, Ladeb S, Ben Othmane T, Hmida S.
    Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
    [Abstract] [Full Text] [Related]

  • 6. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease.
    Behar E, Chao NJ, Hiraki DD, Krishnaswamy S, Brown BW, Zehnder JL, Grumet FC.
    N Engl J Med; 1996 Feb 01; 334(5):286-91. PubMed ID: 8532023
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N, Chehata S, Esperou H, Vernant JP, Michallet M, Buzyn A, Gratecos N, Cahn JY, Bourhis JH, Chir Z, Raffoux C, Socié G, Golmard JL, Jouet JP, French Society of Bone Marrow Transplantation and Cell Therapy.
    J Clin Oncol; 2006 Dec 20; 24(36):5695-702. PubMed ID: 17116940
    [Abstract] [Full Text] [Related]

  • 8. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling.
    El-Chennawi FA, Kamel HA, Mosaad YM, El-Sherbini SM, El-Billey NA.
    Hematology; 2006 Aug 20; 11(4):227-34. PubMed ID: 17178660
    [Abstract] [Full Text] [Related]

  • 9. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP, DA WM, Zhao DD, Wang C, Lu XC, Kang HY, Yan P, Wang FF, Zhu HY, Li HH, Gao CJ, Yu L.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3111-4. PubMed ID: 18269867
    [Abstract] [Full Text] [Related]

  • 10. Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation.
    Stark GL, Dickinson AM, Jackson GH, Taylor PR, Proctor SJ, Middleton PG.
    Transplantation; 2003 Dec 27; 76(12):1742-9. PubMed ID: 14688526
    [Abstract] [Full Text] [Related]

  • 11. Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation.
    Tamouza R, Busson M, Rocha V, Fortier C, Haddad Y, Brun M, Boukouaci W, Bleux H, Socié G, Krishnamoorthy R, Toubert A, Gluckman E, Charron D.
    Transplantation; 2006 Dec 15; 82(11):1436-40. PubMed ID: 17164714
    [Abstract] [Full Text] [Related]

  • 12. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
    Murphy N, Diviney M, Szer J, Bardy P, Grigg A, Hoyt R, King B, Macgregor L, Holdsworth R, McCluskey J, Tait BD.
    Bone Marrow Transplant; 2006 Apr 15; 37(8):773-9. PubMed ID: 16518429
    [Abstract] [Full Text] [Related]

  • 13. [Role of polymorphic adhesion molecules in the development of graft-versus-leukemia effect after HLA-matched allogeneic stem cell transplantation].
    Shiobara S, Sato H, Furukawa T, Tsukada J, Yasue S, Takeda H, Togawa A, Taira M, Sakai Y, Aizawa Y, Nakao S.
    Rinsho Ketsueki; 2004 Jul 15; 45(7):518-23. PubMed ID: 15359910
    [Abstract] [Full Text] [Related]

  • 14. CD31 mismatching affects marrow transplantation outcome.
    Grumet FC, Hiraki DD, Brown BWM, Zehnder JL, Zacks ES, Draksharapu A, Parnes J, Negrin RS.
    Biol Blood Marrow Transplant; 2001 Jul 15; 7(9):503-12. PubMed ID: 11669217
    [Abstract] [Full Text] [Related]

  • 15. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation.
    Granell M, Urbano-Ispizua A, Suarez B, Rovira M, Fernández-Avilés F, Martínez C, Ortega M, Uriburu C, Gaya A, Roncero JM, Navarro A, Carreras E, Mensa J, Vives J, Rozman C, Montserrat E, Lozano F.
    Exp Hematol; 2006 Oct 15; 34(10):1435-41. PubMed ID: 16982337
    [Abstract] [Full Text] [Related]

  • 16. Mismatch for the minor histocompatibility antigen HA-2 and GVHD occurrence in HLA-A*0201-positive Tunisian recipients of HSCs.
    Sellami MH, Torjemane L, Espadas de Arias A, Kaabi H, Ladeb S, Ben Othman T, Poli F, Hmida S.
    Immunol Invest; 2010 Oct 15; 39(6):611-20. PubMed ID: 20653428
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation.
    Middleton PG, Cullup H, Dickinson AM, Norden J, Jackson GH, Taylor PR, Cavet J.
    Bone Marrow Transplant; 2002 Aug 15; 30(4):223-8. PubMed ID: 12203138
    [Abstract] [Full Text] [Related]

  • 18. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bogunia-Kubik K, Duda D, Suchnicki K, Lange A.
    Haematologica; 2006 Dec 15; 91(12):1628-34. PubMed ID: 17145599
    [Abstract] [Full Text] [Related]

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
    Danzer M, Polin H, Pröll J, Haunschmid R, Hofer K, Stabentheiner S, Hackl C, Kasparu H, König J, Hauser H, Binder M, Weiss R, Gabriel C, Krieger O.
    Transplantation; 2009 Aug 27; 88(4):528-32. PubMed ID: 19696636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.